{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:49:08Z","timestamp":1773344948527,"version":"3.50.1"},"reference-count":61,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American Association for the Study of the Liver Foundation Clinical and Translation Research Fellowship Award"},{"name":"Yale Liver Center National Institutes of Health","award":["P30 DK34989"],"award-info":[{"award-number":["P30 DK34989"]}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Gastrointestinal bleeding is one of the major causes of death in patients with cirrhosis, and gastroesophageal varices represent the main source of hemorrhage. Even though in the last decades survival has been improved because of the widespread adoption of effective treatments and optimization of general medical care, mortality is still significantly high, and decompensated patients pose a complex challenge\u00a0requiring a multidisciplinary approach that is crucial to improve survival. The aims of this commentary are to review the most recent advances in the management of esophageal variceal bleeding and to highlight useful information to aid hepatologists in clinical practice.<\/ns4:p>","DOI":"10.12688\/f1000research.18807.1","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T09:05:20Z","timestamp":1561453520000},"page":"966","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Management of acute variceal hemorrhage"],"prefix":"10.12688","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-7178","authenticated-orcid":false,"given":"Alberto","family":"Zanetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"952-4","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding.","volume":"361","author":"J Bosch","year":"2003","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"475-505","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension: an evidence-based approach.","volume":"19","author":"G D'Amico","year":"1999","journal-title":"Semin Liver Dis."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"743-52","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.","volume":"63","author":"R de Franchis","year":"2015","journal-title":"J Hepatol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"808-14","DOI":"10.1002\/hep.1840090603","article-title":"Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.","volume":"9","author":"D Kravetz","year":"1989","journal-title":"Hepatology."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1232-40","DOI":"10.1016\/0016-5085(86)90390-2","article-title":"Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution.","volume":"90","author":"D Kravetz","year":"1986","journal-title":"Gastroenterology."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"11-21","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding.","volume":"368","author":"C Villanueva","year":"2013","journal-title":"N Engl J Med."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"406-60","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.","volume":"69","year":"2018","journal-title":"J Hepatol."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"310-35","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.","volume":"65","author":"G Garcia-Tsao","year":"2017","journal-title":"Hepatology."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"1828-34","DOI":"10.1016\/0016-5085(95)90146-9","article-title":"Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.","volume":"108","author":"B Bernard","year":"1995","journal-title":"Gastroenterology."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1207-12","DOI":"10.1002\/hep.510270504","article-title":"Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.","volume":"27","author":"J Goulis","year":"1998","journal-title":"Hepatology."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"746-53","DOI":"10.1002\/hep.20126","article-title":"Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.","volume":"39","author":"M Hou","year":"2004","journal-title":"Hepatology."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"802-6","DOI":"10.1002\/hep.510240408","article-title":"Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.","volume":"24","author":"A Pauwels","year":"1996","journal-title":"Hepatology."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"5317-23","DOI":"10.3748\/wjg.v16.i42.5317","article-title":"Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates.","volume":"16","author":"M Brown","year":"2010","journal-title":"World J Gastroenterol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"1189-1196.e2","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics.","volume":"13","author":"P Tandon","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"362-71","DOI":"10.1016\/j.jhep.2010.01.042","article-title":"Hemostasis and thrombosis in patients with liver disease: the ups and downs.","volume":"53","author":"T Lisman","year":"2010","journal-title":"J Hepatol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"1604-14","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.","volume":"47","author":"J Bosch","year":"2008","journal-title":"Hepatology."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"1123-30","DOI":"10.1053\/j.gastro.2004.07.015","article-title":"Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.","volume":"127","author":"J Bosch","year":"2004","journal-title":"Gastroenterology."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"1377-81","DOI":"10.1136\/bmj.291.6506.1377","article-title":"Desmopressin and bleeding time in patients with cirrhosis.","volume":"291","author":"A Burroughs","year":"1985","journal-title":"Br Med J (Clin Res Ed)."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1102-7","DOI":"10.1002\/hep.1840180514","article-title":"Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.","volume":"18","author":"R de Franchis","year":"1993","journal-title":"Hepatology."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"698-705","DOI":"10.1002\/hep.25684","article-title":"Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study.","volume":"56","author":"Y Hsu","year":"2012","journal-title":"Hepatology."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"588-94","DOI":"10.1002\/hep.20593","article-title":"Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial.","volume":"41","author":"N Shaheen","year":"2005","journal-title":"Hepatology."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1265-72","DOI":"10.1002\/hep.28737","article-title":"Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.","volume":"64","author":"G Dam","year":"2016","journal-title":"Hepatology."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"753\u20139.e1-2","DOI":"10.1016\/j.cgh.2014.07.060","article-title":"Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.","volume":"13","author":"J O'Leary","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1177-86","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.","volume":"113","author":"J Bajaj","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1267-78","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds.","volume":"35","author":"M Wells","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"865-8","DOI":"10.1016\/s0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients.","volume":"346","author":"S Levacher","year":"1995","journal-title":"Lancet."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"e12826","DOI":"10.1097\/MD.0000000000012826","article-title":"Is additional 5-day vasoactive drug therapy necessary for acute variceal bleeding after successful endoscopic hemostasis?: A systematic review and meta-analysis.","volume":"97","author":"P Yan","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"1294-9","DOI":"10.1111\/j.1440-1746.2009.05903.x","article-title":"Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage.","volume":"24","author":"Y Hsu","year":"2009","journal-title":"J Gastroenterol Hepatol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"844-53","DOI":"10.1136\/gutjnl-2017-314653","article-title":"Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial.","volume":"68","author":"M Ibrahim","year":"2019","journal-title":"Gut."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1957-67","DOI":"10.1002\/hep.28360","article-title":"Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial.","volume":"63","author":"A Escorsell","year":"2016","journal-title":"Hepatology."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"823-32","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis.","volume":"362","author":"G Garcia-Tsao","year":"2010","journal-title":"N Engl J Med."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"229-36","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.","volume":"48","author":"J Abraldes","year":"2008","journal-title":"J Hepatol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1872-8","DOI":"10.1038\/ajg.2012.313","article-title":"The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors.","volume":"107","author":"L Amitrano","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"1335-45","DOI":"10.1007\/s10620-018-5412-x","article-title":"Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).","volume":"64","author":"S Maimone","year":"2019","journal-title":"Dig Dis Sci."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"626-31","DOI":"10.1016\/S0016-5085(99)70455-5","article-title":"Prognostic value of early measurements of portal pressure in acute variceal bleeding.","volume":"117","author":"E Moitinho","year":"1999","journal-title":"Gastroenterology."},{"key":"ref-36","doi-asserted-by":"crossref","first-page":"793-801","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.","volume":"40","author":"A Monescillo","year":"2004","journal-title":"Hepatology."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"2370-9","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding.","volume":"362","author":"J Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N Engl J Med."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"282-93","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.","volume":"69","author":"V Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"73-81","DOI":"10.1016\/j.jhep.2017.09.002","article-title":"Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.","volume":"68","author":"D Thabut","year":"2017","journal-title":"J Hepatol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"1297-1310","DOI":"10.1136\/gutjnl-2018-317057","article-title":"Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.","volume":"68","author":"Y Lv","year":"2019","journal-title":"Gut."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"823-33","DOI":"10.1111\/liv.12452","article-title":"Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.","volume":"34","author":"A Puente","year":"2014","journal-title":"Liver Int."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1219-31","DOI":"10.1002\/hep.29267","article-title":"Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.","volume":"66","author":"A Albillos","year":"2017","journal-title":"Hepatology."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"S103-S104","DOI":"10.1016\/S0168-8278(17)30468-3","article-title":"A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: A meta-analysis.","volume":"66","author":"L Turco","year":"2017","journal-title":"J Hepatol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"1017-22","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.","volume":"52","author":"T Serst\u00e9","year":"2010","journal-title":"Hepatology."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"1096-1104.e9","DOI":"10.1016\/j.cgh.2016.01.012","article-title":"Nonselective \u03b2-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis.","volume":"14","author":"S Chirapongsathorn","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"1737-46","DOI":"10.1007\/s10620-018-5092-6","article-title":"Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.","volume":"63","author":"A Facciorusso","year":"2018","journal-title":"Dig Dis Sci."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"1680-1690.e1","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"146","author":"M Mandorfer","year":"2014","journal-title":"Gastroenterology."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"532-4","DOI":"10.1016\/j.jhep.2015.12.012","article-title":"Beta blockers in cirrhosis: The window re-opens.","volume":"64","author":"G Garcia-Tsao","year":"2016","journal-title":"J Hepatol."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"949-58","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.","volume":"68","author":"L Turco","year":"2018","journal-title":"J Hepatol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"1304-12","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers.","volume":"36","author":"U Bang","year":"2016","journal-title":"Liver Int."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"411-21","DOI":"10.1148\/radiology.212.2.r99au46411","article-title":"TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.","volume":"212","author":"A Luca","year":"1999","journal-title":"Radiology."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"612-22","DOI":"10.1002\/hep.510300316","article-title":"Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.","volume":"30","author":"G Papatheodoridis","year":"1999","journal-title":"Hepatology."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"507-16","DOI":"10.1097\/MCG.0b013e31815576e6","article-title":"Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update.","volume":"42","author":"M Zheng","year":"2008","journal-title":"J Clin Gastroenterol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"581-9","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + \u03b2-blocker for prevention of variceal rebleeding.","volume":"63","author":"I Holster","year":"2016","journal-title":"Hepatology."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"660-8.e1","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.","volume":"149","author":"T Sauerbruch","year":"2015","journal-title":"Gastroenterology."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"1160-1170.e3","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.","volume":"150","author":"J Abraldes","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"670-6; quiz e58","DOI":"10.1016\/j.cgh.2012.02.011","article-title":"Patients whose first episode of bleeding occurs while taking a \u03b2-blocker have high long-term risks of rebleeding and death.","volume":"10","author":"A de Souza","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"1381-5","DOI":"10.1097\/MEG.0b013e328357d5d4","article-title":"Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.","volume":"24","author":"L Amitrano","year":"2012","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"152-6","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation.","volume":"46","author":"A Dell\u2019Era","year":"2014","journal-title":"Dig Liver Dis."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"2156-68","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.","volume":"67","author":"Y Lv","year":"2018","journal-title":"Gut."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"1318-29","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis.","volume":"31","author":"A Zanetto","year":"2018","journal-title":"Transpl Int."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-966\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-966\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-966\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T09:35:53Z","timestamp":1561455353000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-966\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":61,"URL":"https:\/\/doi.org\/10.12688\/f1000research.18807.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.20606.r50385","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.20606.r50387","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.20606.r50384","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-966\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.20606.r50384, Li Yang, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China, 25 Jun 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-966\/v1#referee-response-50384","order":0,"name":"referee-response-50384","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.20606.r50385, Jacques Deviere, Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme Hospital, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium, 25 Jun 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-966\/v1#referee-response-50385","order":1,"name":"referee-response-50385","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.20606.r50387, Thomas Reiberger, Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 25 Jun 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-966\/v1#referee-response-50387","order":2,"name":"referee-response-50387","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The present study was supported by an American Association for the Study of the Liver Foundation Clinical and Translation Research Fellowship Award and a Yale Liver Center National Institutes of Health grant (P30 DK34989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}